Advertisement

Topics

DisperSol Technologies Announces New R&D Data to Be Presented at 2017 Annual Meeting of AAPS  

17:07 EST 8 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
DisperSol Technologies LLC, a clinical stage pharmaceutical company developing a product pipeline of reformulated poorly water-soluble drugs, announced today that it will be hosting a technology symposium entitled “Enhanced Am...

Other Sources for this Article

DisperSol Technologies LLC
Raj Sheel, 512-686-5185
Vice President, Business Development & Marketing
raj.sheel@dispersoltech.com

NEXT ARTICLE

More From BioPortfolio on "DisperSol Technologies Announces New R&D Data to Be Presented at 2017 Annual Meeting of AAPS  "

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...